EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors on long-term local control

Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results

Risk of bleeding-related adverse events in ibrutinib treated CLL patients

The p-medicine project and ECRIN

Quality of life in head and neck cancer patients

Management of the head and neck in locally advanced oral cancers

The American head and neck society: advocacy for patients

Control of migratory and invasive strategies in tumour cells

Radiation and immunology – a new therapeutic partnership

Chemoresistance and residual disease promoted by DNMT3A R882 in AML

New definition for multiple myeloma improves patient outcomes

Expert overview on the recent developments in mantle cell lymphoma